IART Q4 2025 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena

IARTIntegra LifeSciences Holdings Corporation

$738M

Q4 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$435M-1.7% YoY

Gross Profit

$215M49.5% margin

Operating Income

$556M127.9% margin

Net Income

-$2M-0.4% margin

EPS (Diluted)

$-0.02

QoQ Revenue Growth

+8.2%

Cash Flow

Operating Cash Flow

$12M

Free Cash Flow

-$37M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$3.6B

Total Liabilities

$2.6B

Stockholders' Equity

$1.0B

Cash & Equivalents

$235M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$435M	$443M	-1.7%
Gross Profit	$215M	$249M	-13.5%
Operating Income	$556M	$36M	+1461.2%
Net Income	-$2M	$19M	-108.8%

Revenue Segments

Codman Specialty Surgical

$323M74%

Tissue Technologies

$112M26%

Geographic Segments

UNITED STATES

$320M74%

Asia Pacific

$54M12%

Europe

$42M10%

Rest Of The World

$19M4%